期刊文献+

系统性红斑狼疮患者血清脂质水平与病情活动的相关分析 被引量:3

Analysis of the Relationship between Lipid Profile and Disease Aactivity in Patients with Systemic Lupus Erythematosus
下载PDF
导出
摘要 目的评估未经治疗的系统性红斑狼疮(SLE)患者血清脂质水平,探讨其与SLE病情活动关系。方法分别检测38例未经治疗的SLE患者及30例健康查体者血清脂质水平,比较两组血清脂质水平的差异,并分析SLE患者组血清脂质水平与SLE患者病情活动的关系。结果未经治疗的SLE患者血清TG和VLDL水平较对照组增高,HDL水平较对照组降低。HDL水平与SLE疾病活动指数(SLEDAI)及ds-DNA滴度呈负相关,与补体C3和补体C4水平呈正相关。结论在未经治疗的SLE患者中,脂代谢异常已经存在,其中HDL与SLE病情活动密切相关。 Objective To assess the lipid profiles in lupus erythematosus patients without any theapy , approach the relationship between lipid profile and disease activity in systemic lupus erythematosus patients. Methods Fasting blood samples taken from 38 patients of systemic lupus erythematosus (SLE) and 30 healthy controls were assessed for total cholesterol (TC), triglyceride(TG), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) -cholesterol, and compared the results of the two teams, and analysis of the relationship between lipid profile and disease activity in systemic lupus erythematosus patients. Results A significant elevation of TG ,VLDL levels was observed in the SLE patients compared to that of controls( P 〈 0.01 ). The HDL level was also significantly lower in SLE patients than that of controls( P 〈 0.01 ). Moreover, HDL levels were found to be negatively correlated with SLEDAI scores and dsDNA tite, but positively to C3 and C4 levels of addiments. Conclusion Our findings show that SLE patients without any therapy have a lipid profile abnormality , and a significant correlation was found between SLEDAI scores and HDL levels.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2007年第5期280-282,共3页 The Chinese Journal of Dermatovenereology
关键词 红斑狼疮 系统性 血清脂质 SLE疾病活动指数 SLE Lipid profile SLEDAI
  • 相关文献

参考文献8

  • 1Nuttall SL,Heaton S,Piper MK,et al.Cardiovascular risk in systemic lupus erythematosus-evidence of increased oxidative stress and dyslipidaemia[J].Rheumatology,2003,42 (6):758-762. 被引量:1
  • 2Carlk WF,Moist LM.Management of chronic renal insufficiency in lupus nephritis:Role of proteinuria,hypertension and dyslipidemia in the progression of renal disease[J].Lupus,1998,7 (9):649-653. 被引量:1
  • 3Borba EF,Bonfa E,Dyslipoproteinemias in systemic lupus erythematosus:influence of disease activity and anticardiolipin antibodies[J].Lupus,1997,6(6):553 -559. 被引量:1
  • 4张文,李芹,曾学军,唐福林.五种系统性红斑狼疮活动指数的比较[J].中华风湿病学杂志,2001,5(1):35-38. 被引量:55
  • 5Formiga F,Meco JF,Pinto X,et al.Lipid and lipoprotein levels in premenopa-usal systemic lupus erythematosus patients[J].Lupus,2001,10(5):359 -363. 被引量:1
  • 6李娅,陈楠,刘章锁.血脂与肾间质纤维化[J].国外医学(内科学分册),2001,28(10):429-432. 被引量:15
  • 7Delgado Alves J,Ames PR,Donohue S,et al.Antibodies to high-density lipoprotein and beta2-glycoprotein are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome[J].Arthritis Rheum,2002,46 (10):2686-2694. 被引量:1
  • 8Siripaitoon B,Osiri M,Vongthavaravat V,et al.The prevalence of dyslipo-proteinemia in Thai patients with systemic lupus erythematosus[J].Lupus,2004,13 (12):961-968. 被引量:1

二级参考文献26

  • 1[1]Guijarro C, Blanco-Colio LM, Ortego M, et al. [J].Circ Res, 1998,83:490-500. 被引量:1
  • 2[2]Kasiske BL, O' Donnel MP, Keane WF. [J]. Kidney Int, 1988,33:667-672. 被引量:1
  • 3[3]Kasiske BL, O' Donnel MP, Keane WF. [J]. Kidney Int, 1989,35:40-47. 被引量:1
  • 4[4]Pomerantz KB, Lander HM, Summers B. [J]. Biochemistry, 1997,36:9523-9531. 被引量:1
  • 5[5]Kamanna VS, Bassa BV, Vaziri ND,et al. [J]. Kidney Int, 1999,56(Suppl 71) :S70-S75. 被引量:1
  • 6[6]Liao JK,Clark SL. [J]. J Clin Invest, 1995,95:1457-1463. 被引量:1
  • 7[7]Chakrabarti R, Englishman EG. [J]. J Biol Chem,1991,266:122216-122222. 被引量:1
  • 8[8]Fukada Y, Takao T, Ohguro, H et al. [J]. Nature,1990,346: 658-660. 被引量:1
  • 9[9]Tamaki K,Okuda S,Ando T. [J]. Kidney Int, 1994,45: 525-536. 被引量:1
  • 10[10]Vrtovsnik F,Couette S,Prie D,et al. [J]. Kidney Int,1997,52:1016-1027. 被引量:1

共引文献68

同被引文献40

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部